[Thymopentin and cervico-vaginal HPV infection associated with CIN].
46 patients affected by HPV+CIN were treated with Thymopentin i.m. HPV disappeared in all cases. We also observed complete disappearance or only a partial remission of CIN in 82.6% of cases.
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000328:Adult; D005260:Female; D006801:Humans; D008875:Middle Aged; D027383:Papillomaviridae / Q000187:drug effects; D030361:Papillomavirus Infections / Q000150:complications / Q000188:drug therapy*; D016305:Thymopentin / Q000627:therapeutic use*; D014412:Tumor Virus Infections / Q000150:complications / Q000188:drug therapy* / Q000821:virology; D014623:Vaginal Diseases / Q000188:drug therapy / Q000821:virology; D002578:Uterine Cervical Dysplasia / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology / Q000821:virology
D000276:Adjuvants, Immunologic; D016305:Thymopentin
Timopentina ed infezione cervico-vaginale HPV associata a CIN.